Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (M(pro)) by using STD-NMR spectroscopy, in silico studies and antiviral assays

SARS-CoV-2 Main protease (M(pro)) is a well-known drug target against SARS-CoV-2 infection. Identification of M(pro) inhibitors is vigorously pursued due to its crucial role in viral replication. The present study was aimed to identify M(pro) inhibitors via repurposing of US-FDA approved drugs by ST...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Abdul Mateen, Atia-tul-Wahab, Farooq, Saba, Ullah, Asmat, Choudhary, M. Iqbal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896891/
https://www.ncbi.nlm.nih.gov/pubmed/36740128
http://dx.doi.org/10.1016/j.ijbiomac.2023.123540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896891/
https://www.ncbi.nlm.nih.gov/pubmed/36740128
http://dx.doi.org/10.1016/j.ijbiomac.2023.123540

Ejemplares similares